Appeared on November 23, 2011
Elliot Schreiber, Ph.D., executive director of LeBow's Center for Corporate Reputation Management, was quoted in an Asbury Park Press story that traces the turbulent past and uncertain future of Johnson and Johnson as the company prepares to launch a new prostate cancer drug. Says Schreiber: “Everyone wanted Johnson & Johnson to be a success because it was the gold standard. It’s no longer a gold standard. They look human."